Commercialising A Unique Solution For Antibiotic Resistance
Helperby Therapeutics Addresses A Clear Unmet Need In Areas Of Significant Market Value
Helperby has three development candidates in clinical trials:
- HY-001 (Urinary Tract Infection) - Phase I completed
- HY-004 (Nasal MRSA) - Phase II
- HY-007 (Consumer Antibacterial) - Market ready
View full development candidate pipeline »
We are actively seeking business development partners.
We help other companies to rescue their antibiotics from resistance
Helperby has worked with companies which are in different stages of development.
Please contact us to discuss your requirements.
Copyright © 2017 Helperby : All Rights Reserved